"I encourage patients to approach all investigational peptides with the same level of caution many have compelling mechanistic or pre-clinical data, but human evidence remains limited." CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER Although many of these peptides are "supported by a compelling biological rationale," Kahn stressed that treatment decisions should be individualized and "made with a physician who understands both the potential benefits, risks and uncertainties."
The result is a dry, porous solid that holds its structure and dissolves again quickly when liquid is added
Alonso Martin, MD, a licensed physician with a background in neuroscience, family medicine, longevity-focused care, and wellness optimization
This comparison illustrates the gap between novel molecular mechanism discovery and validated clinical translation Dihexa represents frontier neuroscience with unresolved questions, while Cerebrolysin represents established but less mechanistically precise neurotrophic therapy
What does faster turnover mean practically